This trial is studying trastuzumab deruxtecan (T-DXd) in patients with certain types of breast cancer. It focuses on those with HER2-low or HER2 IHC 0 breast cancer, whether they are hormone receptor-negative or positive. The main goal is to understand how long patients can benefit from this treatment before needing another therapy.
The trial's ID number is NCT05950945. This is a Phase 3 trial, which means it is looking at how well the treatment works and how safe it is. It is regulated by the FDA, and the trial hopes to include around 250 participants.
Who can join
Adults aged 18 and older can join this trial. It is open to both men and women with specific types of breast cancer that cannot be removed or has spread. Participants should have had one or two previous treatments for their cancer. Those with certain health issues or past treatments may not be eligible. The trial team will confirm who can join.
Condition
Breast Cancer
Age group
Adult, Older adult
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Participants will receive trastuzumab deruxtecan (T-DXd) through an IV. They will be put into groups based on their cancer type. All groups will receive T-DXd, which will be given every 21 days until the cancer progresses or certain safety criteria are met.
Where
This trial is enrolling at 5 locations. Recruiting sites are listed first.
Dana-Farber Cancer Institute
Boston, Massachusetts
Recruiting
Overlook Medical Center
Summit, New Jersey
Recruiting
Beth Israel Lahey Health
Burlington, Massachusetts
Withdrawn
Mount Sinai Medical Center
Miami Beach, Florida
Terminated
USF College of Medicine
Tampa, Florida
Withdrawn
Study contact
(US Sites) Daiichi Sankyo Contact for Clinical Trial Information
Director of the Breast Cancer Center at NYU Langone’s Perlmutter Cancer Center. Treats breast cancer. The main cancer doctor for adults. Manages your treatment and your care team. Recognized at state, national or international level.
Inaugural Jeffrey F. Moley Professor of Endocrine and Oncologic Surgery, WashU. Treats breast cancer. A surgeon is the doctor who removes cancer with an operation (adults). Recognized at state, national or international level.
Microsurgical breast reconstruction specialist, MSK. Treats breast cancer and mouth cancer. Offers microsurgical breast reconstruction, head and neck reconstruction and abdominal wall reconstruction.